Janet Dillione - 22 Feb 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Janet Dillione
Issuer symbol
CRMD
Transactions as of
22 Feb 2022
Net transactions value
$0
Form type
4
Filing time
23 Feb 2022, 16:43:13 UTC
Next filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 53,473 22 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +20,000 $0.000000 20,000 22 Feb 2022 Common Stock 20,000 $4.03 Direct F9
holding CRMD Stock Option (Right to Buy Common Stock) 30,000 22 Feb 2022 Common Stock 30,000 $8.32 Direct F1
holding CRMD Phantom Stock 3,583 22 Feb 2022 Common Stock 3,583 $0.000000 Direct F2
holding CRMD Phantom Stock 4,770 22 Feb 2022 Common Stock 4,770 $0.000000 Direct F2
holding CRMD Phantom Stock 5,253 22 Feb 2022 Common Stock 5,253 $0.000000 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15,000 22 Feb 2022 Common Stock 15,000 $5.63 Direct F3
holding CRMD Phantom Stock 1,706 22 Feb 2022 Common Stock 1,706 $0.000000 Direct F2
holding CRMD Phantom Stock 2,099 22 Feb 2022 Common Stock 2,099 $0.000000 Direct F2
holding CRMD Phantom Stock 945 22 Feb 2022 Common Stock 945 $0.000000 Direct F2
holding CRMD Phantom Stock 1,126 22 Feb 2022 Common Stock 1,126 $0.000000 Direct F2
holding CRMD Phantom Stock 843 22 Feb 2022 Common Stock 843 $0.000000 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15,000 22 Feb 2022 Common Stock 15,000 $8.30 Direct F4
holding CRMD Phantom Stock 1,328 22 Feb 2022 Common Stock 1,328 $0.000000 Direct F2
holding CRMD Phantom Stock 2,728 22 Feb 2022 Common Stock 2,728 $0.000000 Direct F2
holding CRMD Phantom Stock 7,500 22 Feb 2022 Common Stock 7,500 $0.000000 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 8,000 22 Feb 2022 Common Stock 8,000 $2.85 Direct F5
holding CRMD Phantom Stock 2,679 22 Feb 2022 Common Stock 2,679 $0.000000 Direct F2
holding CRMD Phantom Stock 3,125 22 Feb 2022 Common Stock 3,125 $0.000000 Direct F2
holding CRMD Phantom Stock 4,167 22 Feb 2022 Common Stock 4,167 $0.000000 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 8,000 22 Feb 2022 Common Stock 8,000 $11.20 Direct F6
holding CRMD Phantom Stock 695 22 Feb 2022 Common Stock 695 $0.000000 Direct F2
holding CRMD Phantom Stock 829 22 Feb 2022 Common Stock 829 $0.000000 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 10,000 22 Feb 2022 Common Stock 10,000 $15.15 Direct F7
holding CRMD Phantom Stock 283 22 Feb 2022 Common Stock 283 $0.000000 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 19,000 22 Feb 2022 Common Stock 19,000 $9.55 Direct F8
holding CRMD Phantom Stock 767 22 Feb 2022 Common Stock 767 $0.000000 Direct F2
holding CRMD Phantom Stock 554 22 Feb 2022 Common Stock 554 $0.000000 Direct F2
holding CRMD Phantom Stock 867 22 Feb 2022 Common Stock 867 $0.000000 Direct F2
holding CRMD Phantom Stock 3,062 22 Feb 2022 Common Stock 3,062 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/11/2021. These options are fully vested.
F2 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
F3 These options were granted on 02/25/2020. These options are fully vested.
F4 These options were granted on 01/10/2019. These options are fully vested.
F5 These options were granted on 02/16/2018. These options are fully vested.
F6 These options were granted on 02/21/2017. These options are fully vested.
F7 These options were granted on 08/12/2015. These options are fully vested.
F8 These options were granted on 02/21/2016. These options are fully vested.
F9 These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.